Bradycardia and hypotension associated with fomepizole infusion during hemodialysis

References

• http://antizol.info/monograph.htm, Antizol ® (fomepizole) injection product monograph. Jazz Pharmaceuticals. Available at:
   Google Scholar
• Smithline N, Gardner K. Gaps-anionic and osmolal. The Journal of the American Medical Association. 1976; 236(14)1594–1597
   Web of Science ®Google Scholar
• Voyce S, McCaffree D. Pulmonary artery catheters. Irwin & Rippe's Intensive Care Medicine (electronic version)5, R Irwin, R Rippe. Lippincott Williams & Wilkins, Philadelphia 2003; 56
   Google Scholar
• Davenport A. Intradialytic complications during hemodialysis. Hemodialysis International. 2006; 10: 162–167
   PubMedGoogle Scholar
• Zoccali C, Tripepi G, Mallamaci F, Panuccio V. The heart rate response pattern to dialysis hypotension in hemodialysis. Nephrology Dialysis Transplantation. 1997; 12: 519–523
   PubMed Web of Science ®Google Scholar
• Magnusson G, Nyberg J, Bodin N, Hansson E. Toxicity of pyrazole and 4- methylpyrazole in mice and rats. Experientia. 1972; 28: 1198–1200
   PubMedGoogle Scholar
• Blomstrand R, Ellin A, Lof A, Ostling-Wintzell H. Biological effects and metabolic interactions after chronic and acute administration of 4-methylpyrazole and ethanol to rats. Archives of Biochemistry & Biophysics Feb, 1980; 199(2)591–605
   PubMed Web of Science ®Google Scholar
• Jacobsen D, Sebastian CS, Barron SK, Carriere EW, McMartin KE. Effects of 4-methylpyrazole, methanol/ethylene glycol antidote, in healthy humans. Journal of Emergency Medicine. 1990; 8(4)455–461
   PubMedGoogle Scholar
• Jacobsen D, Sebastian CS, Blomstrand R, McMartin KE. 4-Methylpyrazole: a controlled study of safety in healthy human subjects after single, ascending doses. Alcoholism: Clinical & Experimental Research. 1988; 12(4)516–522
   PubMed Web of Science ®Google Scholar
• Brent J, McMartin K, Phillips S, et al. Fomepizole for the treatment of ethylene glycol poisoning. New England Journal of Medicine. 1999; 340(11)832–838
   PubMed Web of Science ®Google Scholar
• Brent J, McMartin K, Phillips S, Aaron C, Kulig K. Fomepizole for the treatment of methanol poisoning. New England Journal of Medicine 2001; 344(6)424–429
   PubMed Web of Science ®Google Scholar
• Baud FJ, Bismuth C, Garnier R, et al. 4-Methylpyrazole may be an alternative to ethanol therapy for ethylene glycol intoxication in man. Journal of Toxicology – Clinical Toxicology. 1986; 24(6)463–483
   PubMed Web of Science ®Google Scholar
• Baud FJ, Galliot M, Astier A, et al. Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole. New England Journal of Medicine. 1988; 319(2)97–100
   PubMed Web of Science ®Google Scholar
• Hantson P, Wallemacq P, Brau M, Vanbinst R, Haufroid V, Mahieu P. Two cases of acute methanol poisoning partially treated by oral 4-methylpyrazole. Intensive Care Medicine. 1999; 25(5)528–531
   PubMed Web of Science ®Google Scholar
• Megarbane B, Borron SW, Trout H, et al. Treatment of acute methanol poisoning with fomepizole. Intensive Care Medicine. 2001; 27(8)1370–1378
   PubMed Web of Science ®Google Scholar
• Borron SW, Megarbane B, Baud FJ. Fomepizole in treatment of uncomplicated ethylene glycol poisoning. Lancet. 1999; 354(9181)831
   PubMed Web of Science ®Google Scholar
• Orth RE. Biologically active pyrazoles. Journal of Pharmaceutical Sciences 1968; 57(4)537–556
   PubMed Web of Science ®Google Scholar
• Lieber C, Rubin E, DeCarli L, Misra P, Gang H. Effects of pyrazole on hepatic function and structure. Laboratory Investigation. 1970; 22(6)615–621
   PubMed Web of Science ®Google Scholar
• Wilson W, Bottiglieri N. Phase I studies with pyrazole. Cancer Chemotherapy Reports. 1962; 21: 137–141
   PubMedGoogle Scholar
• Foley H, Shnider B, Gold G, Uzer Y. Phase I studies of pyrazole (NSC-45410). Cancer Chemotherapy Reports. 1965; 44: 45–48
   PubMedGoogle Scholar
• Eckle T, Ghanayim N, Trick M, Unertl K, Eltzschig H. Intraoperative metamizol as a cause for acute anaphylactic collapse. European Journal of Anaesthesiology. 2005; 22: 810–812
   PubMed Web of Science ®Google Scholar
• Janke C, Schmeck J, Passani D, Dodidou P, Struck B, Kerger H. Anaphylaktisches herzkreislauf-versagen nach intraoperativer metamizolapplikation. (German, English abstract). Anaesthesist. 2003; 52(321–325)
   PubMedGoogle Scholar
• Avellaneda C, Gomez A, Martos F, Rubio M, Sarmiento J, de la Cuesta F. The effect of a single intravenous dose of metamizol 2 g, ketorolac 30 mg and propacetamol 1 g on haemodynamic parameters and postoperative pain after heart surgery. European Journal of Anaesthesiology. 2000; 17: 85–90
   PubMed Web of Science ®Google Scholar
• Gozzoli V, Treggiari M, Kleger G, et al. Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Medicine. 2004; 30: 401–407
   PubMed Web of Science ®Google Scholar
• Poblete B, Romand J, Pichard C, Konig P, Suter P. Metabolic effects of i.v. propacetamol, metamizol or external cooling in critically ill febrile sedated patients. British Journal of Anaesthesia. 1997; 78: 123–127
   PubMed Web of Science ®Google Scholar
• Braun R, Buche I, Maier P, Thiele H. Perioperative analgesia with intraoperatively started infusion of high-dose dipyrone in orthopaedic and trauma surgery. Acute Pain. 1999; 2(4)167–171
   Google Scholar
• Kampe S, Warm M, Landwehr S, et al. Clinical equivalence of IV paracetamol compared to IV dipyrone for postoperative analgesia after surgery for breast cancer. Current Medical Research and Opinion. 2006; 22(10)1949–1954
   PubMed Web of Science ®Google Scholar
• Cruz P, Garutti I, Diaz S, Fernandez-Quero L. Metamizol frente a propacetamol: estudio comparativo de los efectos hemodinámicos y antipiréticos en pacientes críticamente enfermos. (Spanish, English abstract). Revista Española de Anestesiología y Reanimación. 2002; 49: 391–396
   PubMedGoogle Scholar